STOCK TITAN

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results

(Neutral)
Tags
conferences earnings

Zimmer Biomet (NYSE: ZBH) will webcast its first quarter 2026 earnings conference call on Tuesday, April 28, 2026 at 8:30 a.m. ET. A quarterly results news release will be posted that day at 6:30 a.m. ET. The live audio webcast and replay will be available via the company's Investor Relations website, and U.S./Canada dial-in and international telephone numbers with conference ID are provided for live participation.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ZBH

+0.02%
+0.02% Session close to close

In the Apr 9 session, ZBH gained 0.02%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules Zimmer Biomet’s Q1 2026 results release at 6:30 a.m. ET with an earnings...
Analysis

This announcement schedules Zimmer Biomet’s Q1 2026 results release at 6:30 a.m. ET with an earnings call at 8:30 a.m. ET, continuing a consistent communication pattern seen in prior quarters. No new financial metrics are disclosed here; those arrive with the earnings release. Investors watching this type of notice typically focus on upcoming results versus prior figures like $8.232B 2025 sales and $8.20 adjusted EPS.

Key Figures

Q4 2025 net sales: $2.244B FY 2025 net sales: $8.232B Q4 2025 adjusted EPS: $2.42 +5 more
8 metrics
Q4 2025 net sales $2.244B Quarter ended Q4 2025
FY 2025 net sales $8.232B Full-year 2025
Q4 2025 adjusted EPS $2.42 Quarter ended Q4 2025
FY 2025 adjusted EPS $8.20 Full-year 2025
Operating cash flow $1.697B Full-year 2025
Free cash flow $1.172B Full-year 2025
Share repurchase authorization $1.5B Authorized Feb 9, 2026
2026 adjusted EPS guidance $8.30–$8.45 Full-year 2026 guidance

Previous Conferences,earnings Reports

5 past events · Latest: Jan 15 (Neutral)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jan 15 Earnings call notice Neutral -0.6% Announced Q4 2025 webcast and call schedule with dial-in details.
Oct 03 Earnings call notice Neutral +1.6% Announced Q3 2025 webcast and conference call timing and access.
Jul 09 Earnings call notice Neutral +1.9% Scheduled Q2 2025 financial results call and webcast details.
Apr 10 Earnings call notice Neutral -1.1% Set Q1 2025 earnings conference call and webcast timing.
Jan 16 Earnings call notice Neutral +2.3% Announced Q4 2024 financial results conference call schedule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Scheduling earnings webcasts has historically led to modest single-day moves, with both small gains and declines around the announcements.

Recent Company History

Over the past year, Zimmer Biomet has repeatedly issued notices for quarterly earnings webcasts, typically releasing results at 6:30 a.m. ET followed by calls at 8:30 a.m. ET. These “conferences,earnings” announcements (e.g., on Jan 16, 2025 and Jan 15, 2026) produced modest price reactions ranging from about -1.14% to +2.28%. Today’s Q1 2026 webcast notice continues this pattern of standard pre-earnings communication without new financial figures.

Key Terms

investor relations, restricted stock units (rsus), phantom stock units, deferred compensation plan, +1 more
5 terms
investor relations financial
"A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website"
Investor relations is the communication process between a company and its current or potential investors. It involves sharing information about the company's performance, strategies, and outlook to help investors make informed decisions. Effective investor relations build trust and transparency, similar to a clear conversation between a business and someone considering investing, ensuring both parties understand each other's interests and expectations.
restricted stock units (rsus) financial
"reported the vesting and exercise of 6,626 restricted stock units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
phantom stock units financial
"received 182.421 phantom stock units as a compensation award"
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
deferred compensation plan financial
"under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors"
A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.
dividend reinvestment provision financial
"15.067 units accrued on January 30, 2026 through the plan’s dividend reinvestment provision"
A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WARSAW, Ind., April 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.

Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (800) 330-6710 and using conference ID 7090861. International callers should dial +1 (213) 279-1505 and use conference ID 7090861.

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

 

Contacts:


Media

 Investors

Troy Kirkpatrick

David DeMartino

614-284-1926 

646-531-6115

troy.kirkpatrick@zimmerbiomet.com

david.demartino@zimmerbiomet.com



Kirsten Fallon

Zach Weiner

781-779-5561

908-591-6955

kirsten.fallon@zimmerbiomet.com

zach.weiner@zimmerbiomet.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-webcast-and-conference-call-of-first-quarter-2026-financial-results-302737137.html

SOURCE Zimmer Biomet Holdings, Inc.

FAQ

When will Zimmer Biomet (ZBH) hold its Q1 2026 earnings call?

Zimmer Biomet will hold its Q1 2026 earnings call on Tuesday, April 28, 2026 at 8:30 a.m. ET. According to Zimmer Biomet, a news release with quarterly results will be posted that morning at 6:30 a.m. ET and the call will be webcast live for investors.

How can I access the live webcast for Zimmer Biomet (ZBH) April 28, 2026 call?

Access the live webcast via Zimmer Biomet's Investor Relations website at the scheduled time. According to Zimmer Biomet, the live audio webcast will be available on the investor site and a replay will be posted after the conference call for later listening.

What are the dial-in details for Zimmer Biomet (ZBH) April 28, 2026 conference call?

U.S. and Canada callers may dial (800) 330-6710 using conference ID 7090861 to join the call. According to Zimmer Biomet, international participants should dial +1 (213) 279-1505 and use the same conference ID for live audio access.

Will Zimmer Biomet (ZBH) provide a replay of the Q1 2026 earnings call?

Yes, a replay of the Q1 2026 earnings call will be available after the live event on the investor site. According to Zimmer Biomet, the live audio webcast will be accessible for replay following the conference call for investors who cannot join live.

When will Zimmer Biomet (ZBH) publish its Q1 2026 quarterly results before the call?

Zimmer Biomet will publish the Q1 2026 quarterly results news release on April 28, 2026 at 6:30 a.m. ET. According to Zimmer Biomet, the release will precede the 8:30 a.m. ET conference call to allow investors time to review the results.